These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 16150905)

  • 1. Differential biosynthesis and intracellular transport of follistatin isoforms and follistatin-like-3.
    Saito S; Sidis Y; Mukherjee A; Xia Y; Schneyer A
    Endocrinology; 2005 Dec; 146(12):5052-62. PubMed ID: 16150905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological activity of follistatin isoforms and follistatin-like-3 is dependent on differential cell surface binding and specificity for activin, myostatin, and bone morphogenetic proteins.
    Sidis Y; Mukherjee A; Keutmann H; Delbaere A; Sadatsuki M; Schneyer A
    Endocrinology; 2006 Jul; 147(7):3586-97. PubMed ID: 16627583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Follistatin and follistatin like-3 differentially regulate adiposity and glucose homeostasis.
    Brown ML; Bonomi L; Ungerleider N; Zina J; Kimura F; Mukherjee A; Sidis Y; Schneyer A
    Obesity (Silver Spring); 2011 Oct; 19(10):1940-9. PubMed ID: 21546932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparin and activin-binding determinants in follistatin and FSTL3.
    Sidis Y; Schneyer AL; Keutmann HT
    Endocrinology; 2005 Jan; 146(1):130-6. PubMed ID: 15471966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth differentiation factor 9 (GDF9) suppresses follistatin and follistatin-like 3 production in human granulosa-lutein cells.
    Shi FT; Cheung AP; Huang HF; Leung PC
    PLoS One; 2011; 6(8):e22866. PubMed ID: 21829661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of follistatin-like 3 in gonads causes defects in gonadal development and function in transgenic mice.
    Xia Y; Sidis Y; Schneyer A
    Mol Endocrinol; 2004 Apr; 18(4):979-94. PubMed ID: 14739256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential actions of follistatin and follistatin-like 3.
    Schneyer A; Sidis Y; Xia Y; Saito S; del Re E; Lin HY; Keutmann H
    Mol Cell Endocrinol; 2004 Oct; 225(1-2):25-8. PubMed ID: 15451564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression patterns of activin, inhibin and follistatin variants in the adult male mouse reproductive tract suggest important roles in the epididymis and vas deferens.
    Winnall WR; Wu H; Sarraj MA; Rogers PA; de Kretser DM; Girling JE; Hedger MP
    Reprod Fertil Dev; 2013; 25(3):570-80. PubMed ID: 23164397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The follistatin-288 isoform alone is sufficient for survival but not for normal fertility in mice.
    Kimura F; Sidis Y; Bonomi L; Xia Y; Schneyer A
    Endocrinology; 2010 Mar; 151(3):1310-9. PubMed ID: 20032047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure of myostatin·follistatin-like 3: N-terminal domains of follistatin-type molecules exhibit alternate modes of binding.
    Cash JN; Angerman EB; Kattamuri C; Nolan K; Zhao H; Sidis Y; Keutmann HT; Thompson TB
    J Biol Chem; 2012 Jan; 287(2):1043-53. PubMed ID: 22052913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progesterone stimulates expression of follistatin splice variants Fst288 and Fst315 in the mouse uterus.
    Craythorn RG; Winnall WR; Lederman F; Gold EJ; O'Connor AE; de Kretser DM; Hedger MP; Rogers PA; Girling JE
    Reprod Biomed Online; 2012 Mar; 24(3):364-74. PubMed ID: 22285243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel factors in regulation of activin signaling.
    Tsuchida K; Nakatani M; Matsuzaki T; Yamakawa N; Liu Z; Bao Y; Arai KY; Murakami T; Takehara Y; Kurisaki A; Sugino H
    Mol Cell Endocrinol; 2004 Oct; 225(1-2):1-8. PubMed ID: 15451561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of follistatin-type domains and their contribution to myostatin and activin A antagonism.
    Cash JN; Angerman EB; Keutmann HT; Thompson TB
    Mol Endocrinol; 2012 Jul; 26(7):1167-78. PubMed ID: 22593183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of follistatin-related genes is altered in heart failure.
    Lara-Pezzi E; Felkin LE; Birks EJ; Sarathchandra P; Panse KD; George R; Hall JL; Yacoub MH; Rosenthal N; Barton PJ
    Endocrinology; 2008 Nov; 149(11):5822-7. PubMed ID: 18617621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of the activin-inhibin-follistatin system by bone morphogenetic proteins in the zebrafish ovary.
    Li CW; Ge W
    Biol Reprod; 2013 Sep; 89(3):55. PubMed ID: 23843234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential binding and neutralization of activins A and B by follistatin and follistatin like-3 (FSTL-3/FSRP/FLRG).
    Schneyer A; Schoen A; Quigg A; Sidis Y
    Endocrinology; 2003 May; 144(5):1671-4. PubMed ID: 12697670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and Therapeutic Implications of Follistatin in Solid Tumours.
    Shi L; Resaul J; Owen S; Ye L; Jiang WG
    Cancer Genomics Proteomics; 2016 11-12; 13(6):425-435. PubMed ID: 27807065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Follistatin-like 3, an activin A binding protein, is involved in early pregnancy loss.
    Xu Y; Xie J; Wan L; Wang M; Xu Y; Wang H; Dong M
    Biomed Pharmacother; 2020 Jan; 121():109577. PubMed ID: 31810141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human follistatin-related protein: a structural homologue of follistatin with nuclear localization.
    Tortoriello DV; Sidis Y; Holtzman DA; Holmes WE; Schneyer AL
    Endocrinology; 2001 Aug; 142(8):3426-34. PubMed ID: 11459787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of NF-kappaB responsive elements in follistatin related gene (FLRG) promoter.
    Bartholin L; Guindon S; Martel S; Corbo L; Rimokh R
    Gene; 2007 May; 393(1-2):153-62. PubMed ID: 17395406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.